¶ Harle-Tsu
¶ Overview
Harle-Tsu is a sativa-dominant high-CBD cultivar created by crossing two of the most important high-CBD strains in cannabis breeding: Harlequin and Sour Tsunami. The result is a strain that consistently expresses a balanced CBD:THC ratio, typically with CBD levels in the 10-20% range and THC in the 1-5% range. Harle-Tsu is named as a portmanteau of its parent strains, and it has become one of the most reliable cultivars for medical cannabis patients seeking significant therapeutic relief without the intoxicating effects of high-THC cannabis. The strain delivers a terpene profile dominated by caryophyllene, humulene, and myrcene, producing an earthy, woody, and herbal aroma. Harle-Tsu is prized for its clear-headed, functional relief that allows patients to remain active and productive throughout the day.
¶ Quick Stats
| Attribute | Value |
|---|---|
| Type | Sativa-Dominant Hybrid (High-CBD) |
| THC % | 1-5% |
| CBD % | 10-20% |
| CBD:THC Ratio | Approximately 5:1 to 10:1 (varies by phenotype) |
| Dominant Terpenes | Caryophyllene, Humulene, Myrcene |
| Flowering Time | 55-65 days |
| Yield | Moderate (350-450 g/m² indoor) |
| Growing Difficulty | Moderate |
¶ Genetics & Lineage
Harle-Tsu combines two landmark high-CBD genetics:
- Harlequin -- A sativa-dominant high-CBD strain (Colombian Gold x Thai x Swiss Landrace x Nepali Indica) known for its characteristic 5:2 CBD:THC ratio
- Sour Tsunami -- A high-CBD strain created by Lawrence Ringo (Sour Diesel x NYC Diesel CBD), one of the pioneering strains in the CBD breeding movement
Parent lineage: Harlequin x Sour Tsunami
Both parent strains carry significant CBD expression, making Harle-Tsu one of the most reliably high-CBD cultivars available. The cross was designed to concentrate CBD genetics from two independent high-CBD lines, producing offspring that consistently express elevated CBD levels. Both parent strains are connected to the broader movement toward medical cannabis breeding that gained momentum in the 2010s.
¶ Cannabinoid Profile
| Cannabinoid | Typical Range |
|---|---|
| THC (Total) | 1-5% |
| CBD | 10-20% |
| CBD:THC Ratio | Approximately 5:1 to 10:1 (varies significantly by phenotype) |
| CBG | 0.3-1.0% |
| CBN | <0.5% (increases with age) |
Harle-Tsu's cannabinoid profile is its defining characteristic. The very low THC content combined with high CBD expression produces minimal intoxication while delivering significant therapeutic potential from both cannabinoids. The CBD:THC ratio varies by phenotype, and growers are strongly encouraged to test multiple plants to identify those expressing the desired high-CBD ratio. Phenotype selection is critical for medical growers.
¶ Terpene Profile
| Terpene | Approximate Share | Notes |
|---|---|---|
| Caryophyllene | 25-40% | Primary terpene; spicy, peppery character with reported anti-inflammatory properties |
| Humulene | 15-25% | Significant presence; earthy, hoppy depth with reported anti-inflammatory qualities |
| Myrcene | 10-15% | Sweet, herbal notes contributing to the earthy profile |
| Pinene | 5-10% | Pine freshness adding complexity |
| Limonene | 3-7% | Subtle citrus brightness |
The caryophyllene-humulene-myrcene combination produces the earthy, woody, and herbal aroma that defines Harle-Tsu.
¶ Effects & Experience
Harle-Tsu is widely reported to produce:
- Clear-headed relief -- Noticeable therapeutic effects without significant intoxication, allowing users to remain fully functional and productive
- Physical relaxation -- A calming physical effect that reduces tension without sedation
- Mental clarity -- The very low THC content ensures users remain clear-headed and focused
- Sustained functionality -- The effects support all-day use without impairment, making it ideal for working patients
Onset: Effects begin within minutes when smoked or vaporized; 30-90 minutes when consumed orally.
Duration: 2-4 hours for inhaled consumption; 4-8 hours for oral consumption.
Intensity: Mild. The effects are subtle and functional rather than intoxicating, making Harle-Tsu suitable for users who need to remain clear-headed during the day.
⚠️ Effects are self-reported and vary by individual, dose, tolerance, and consumption method. CBD-rich strains like Harle-Tsu produce significantly less intoxication than high-THC strains. Not a prediction of any individual's experience.
¶ Aroma & Flavor
- Smell: Earthy, woody, and herbal with subtle spicy undertones. The caryophyllene-humulene combination gives it a warm, organic quality that is pleasant without being overpowering.
- Taste: Earthy and woody on the inhale, with herbal and slightly spicy notes on the exhale. The flavor is smooth and approachable, appealing to users who may be sensitive to strong cannabis taste.
¶ Medical Usesdanger
Not Medical Advice -- The following lists commonly reported therapeutic applications. This does not constitute medical advice. Consult a healthcare professional before using cannabis therapeutically.
Commonly reported uses include:
- Chronic pain -- The high CBD content combined with caryophyllene and humulene is widely cited for significant pain relief without sedation
- Inflammation -- CBD, caryophyllene, and humulene are all reported for anti-inflammatory effects, making this a triple-action anti-inflammatory strain
- Anxiety -- The high CBD:THC ratio is frequently recommended for anxiety relief, as CBD moderates THC's anxiety-producing effects
- Seizures and epilepsy -- CBD-rich strains are commonly used as part of seizure management protocols, though patients should consult their physician
- Migraines -- Reported to provide relief while maintaining full daytime functionality
- Arthritis -- The anti-inflammatory quality is cited for joint pain and stiffness relief
- Nausea -- The low THC content means Harle-Tsu can be used throughout the day without impairment
¶ Adverse Effects
Commonly reported adverse effects:
- Dry mouth
- Dry eyes
- Mild dizziness (less common than with high-THC strains)
- Headache at higher doses
- The very low THC content means adverse effects are generally minimal
- Some phenotype selections may express higher THC levels, producing more intoxication than expected -- testing is essential
¶ Growing Information
| Attribute | Details |
|---|---|
| Difficulty | Moderate -- requires experience with sativa-dominant growing and phenotype selection |
| Flowering Time | 55-65 days (indoor) -- reasonable for a sativa-dominant strain |
| Yield | 350-450 g/m² indoor; 450+ g/plant outdoor |
| Plant Height | Medium -- sativa stretch is moderate; manageable for most indoor spaces |
| Preferred Environment | Indoor or outdoor; prefers warm, sunny conditions with good air circulation |
| Resistance | Moderate resistance to mold and pests. The diverse genetic heritage from both parent strains contributes resilience. Responds well to topping and SCROG. |
Harle-Tsu is moderately challenging to grow. Its sativa-dominant characteristics require some height management, but the manageable flowering time (55-65 days) is an advantage. For medical growers, phenotype selection is the most critical growing consideration -- growers should test multiple seeds to identify plants expressing the desired high-CBD, low-THC ratio. Phenotypes can vary significantly in their CBD:THC expression. Outdoor harvest in the Northern Hemisphere typically falls in late September to early October.
¶ Awards & Recognition
- Harle-Tsu has not won major recreational Cannabis Cup awards
- The strain is highly valued in the medical cannabis community for its reliable high-CBD expression
- Both parent strains (Harlequin and Sour Tsunami) are landmark cultivars in the CBD breeding movement
- Harle-Tsu represents the continuation of the pioneering work done by Lawrence Ringo and others in developing high-CBD cannabis genetics
¶ Similar Strains
- Harlequin -- Parent lineage; landmark 5:2 CBD:THC ratio strain
- Sour Tsunami -- Parent lineage; pioneering high-CBD strain
- Cannatonic -- Comparable high-CBD medical strain
- ACDC -- Similar very high-CBD, low-THC cultivar
Back to Strain Database | Sativa Strains | Strain Template Guide